Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of APT Phage Bank Phage Therapy Versus Placebo in Conjunction With Debridement, Antibiotics, and Implant Retention (DAIR) in Subjects With Chronic Prosthetic Joint Infection (PJI)
Conditions
Interventions
Bacteriophage
Placebo
Locations
10
United States
University of California San Diego Medical Center
San Diego, California, United States
Hartford Health Care Bone & Joint Insitute
Hartford, Connecticut, United States
Snake River Research
Idaho Falls, Idaho, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
Sinai Hospital of Baltimore
Baltimore, Maryland, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
Start Date
March 27, 2023
Primary Completion Date
July 1, 2025
Completion Date
July 1, 2027
Last Updated
November 30, 2023
NCT07406893
NCT05169229
NCT06062251
NCT06464770
NCT05159739
NCT07358455
Lead Sponsor
Adaptive Phage Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions